An experimental treatment using controversial embryonic stem cells to fix severe spinal cord injuries has new life under a new company. Asterias Biotherapeutics Inc. of Menlo Park received Food and Drug Administration clearance Wednesday to go forward with a 13-person safety study of so-called…
That All May Walk Again!